OHSU Knight Cancer Institute Research Groups:OCI Cancer Journal Club: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Karyn Taylor (talk | contribs) |
Karyn Taylor (talk | contribs) |
||
Line 85: | Line 85: | ||
| | | | ||
|-- | |-- | ||
|11/ | |11/15/2012 | ||
| | | | ||
| | | | ||
| | | | ||
|-- | |-- | ||
|11/ | |11/22/2012 | ||
|xxxxxxxxxx | |xxxxxxxxxx | ||
|THANKSGIVING, NO JOURNAL CLUB | |THANKSGIVING, NO JOURNAL CLUB | ||
|xxxxxxxxxx | |xxxxxxxxxx | ||
|-- | |-- | ||
| | |11/29/2012 | ||
| | | | ||
| | | | ||
| | | | ||
|-- | |-- | ||
|12/ | |12/6/2012 | ||
| | | | ||
| | | | ||
| | | |
Revision as of 11:33, 20 September 2012
Home Faculty Graduate Program Postdocs OHSU Knight Core Facilities
Programs
Res Group Meetings
Cancer Journal Club
Cell/CANB 616
Gen. Inst/R3 Club
CANB 610
Objectives of the OHSU Cancer Biology Journal Club
Cross-departmental journal club composed of students, postdocs, fellows and clinical and basic science faculty with shared interest in basic principles, emerging discoveries, and new therapeutic approaches in Cancer Biology. The goals of the meetings are to:
- Critically evaluate new cutting edge literature on mechanisms underlying the development and maintenance of cancer to inform the development of new therapeutics. Papers should be paradigm shifting and set a backdrop for discussion into therapeutics facilitated by the clinical attendees.
- Provide students, postdocs and fellows with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
KCI CJC Information
Want to join us? All are invited!
- To get on the listserve:
- go to the following web site:
- http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncobio
- follow instructions for subscribing
- To send out your paper
- Send an e-mail to 'oncobioATohsu.edu' with your paper attached
- When and where we meet
- MacHall 2136
- Thursdays noon-1 PM
- Lunch provided by KCI
- Organizer contact information:
- Rosie Sears-searsr@ohsu.edu
- Charlie Lopez- lopezc@ohsu.edu
Member Labs and Affiliations
Lopez Lab Hem Onc
Lloyd Lab CROET
McCullough Lab CROET
Schedule
- Scheduling In Progress
Date | Presenters | Topic | Links & Comments |
9/27/2012 | Rosalie Sears | Organization | |
10/4/2012 | Brittany Allen-Petersen | ||
10/11/2012 | |||
10/18/2012 | |||
10/25/2012 | |||
11/1/2012 | |||
11/8/2012 | |||
11/15/2012 | |||
11/22/2012 | xxxxxxxxxx | THANKSGIVING, NO JOURNAL CLUB | xxxxxxxxxx |
11/29/2012 | |||
12/6/2012 | |||
12/15/2011 | Chuck Pham Jr | Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells | http://www.mendeley.com/research/efficient-delivery-liposomemediated-mgmtsirna-reinforces-cytotoxity-temozolomide-gbminitiating-cells/ |
1/5/2012 | Tim Butler | ||
1/12/2012 | Jared Fischer | Single-molecule transcript counting of stem-cell markers in the mouse intestine. | http://www.nature.com/ncb/journal/v14/n1/full/ncb2384.html |
1/19/2012 | Yulong Su | The Metabolic Regulator ERRa, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer. | http://www.cell.com/cancer-cell/abstract/S1535-6108(11)00318-7 |
1/26/2012 | Yuangang Liu | An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor | Opitz C et al 2011 Nature |
2/2/2012 | Mahnaz Janghorban | ||
2/9/2012 | Tiffany DeVine | ||
2/16/2012 | Jason Link | ||
2/23/2012 | Ellen Langer | ||
3/1/2012 | Aaron Jacobs | BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance | http://www.sciencedirect.com/science/article/pii/S1535610811004387 |
3/8/2012 | Vince Bicocca | TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers | [1] |
3/15/2012 | Gordon Shore, Ph.D. | Regulation of cell death by the Bcl-2 family member Mcl-1 | Vollum seminar, M1441 |
3/22/2012 | John Oyer | Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia | [2] |
4/5/2012 | |||
4/12/2012 | Stacey Lin | The translational landscape of mTOR signalling steers cancer initiation and metastasis | http://www.nature.com/nature/journal/vaop/ncurrent/full/nature10912.html |
4/19/2012 | Juan Liang | Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer | Duncan (2012) |
4/26/2012 | Jeff Wu | Metastasis of tumor cells is enhanced by downregulation of Bit1.
PLoS One. |
[3] |
5/3/2012 | Arthur Edwards | bone metastasis in breast cancer through NOTCH signaling with clinical implications in NOTCH directed therapies | [4] |
5/10/2012 | Xiaoxin Sun | A SUMOylation-Dependent Transcriptional Subprogram is Required for Myc-Driven Tumorigenesis | [5] |
5/17/2012 | Nathalie Javidi-Sharifi | Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance | [6] |
5/24/2012 | Nichole Owen | Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma | [7] |
5/31/2012 | Zhiping Wang | Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism | [8] |
6/7/2012 | Kishore Challagundla | Negative Regulation of the Stability and Tumor Suppressor Function of Fbw7 by the Pin1 Prolyl Isomerase | [9] [10] |